Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23944300 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety, Antiviral Effect and PK of BI 207127 + BI 201335 +/- RBV for 4 up to 40 Weeks in Patients With Chronic HCV Genotype 1 Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: BI 207127;   Drug: BI 201335;   Drug: Ribavirin;   Drug: BI 207217

Indicates status has not been verified in more than two years